|Institutional Source||Beutler Lab|
|Gene Name||phosphodiesterase 8A|
|Is this an essential gene?||Non essential (E-score: 0.000)|
|Stock #||R7067 (G1)|
|Chromosomal Location||81213596-81334533 bp(+) (GRCm38)|
|Type of Mutation||missense|
|DNA Base Change (assembly)||T to C at 81317326 bp|
|Amino Acid Change||Valine to Alanine at position 405 (V405A)|
|Ref Sequence||ENSEMBL: ENSMUSP00000026672 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000026672]|
|Predicted Effect||probably benign
AA Change: V405A
PolyPhen 2 Score 0.412 (Sensitivity: 0.89; Specificity: 0.90)
AA Change: V405A
|Coding Region Coverage||
|Validation Efficiency||98% (62/63)|
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The protein encoded by this gene belongs to the cyclic nucleotide phosphodiesterase (PDE) family, and PDE8 subfamily. This PDE hydrolyzes the second messenger, cAMP, which is a regulator and mediator of a number of cellular responses to extracellular signals. Thus, by regulating the cellular concentration of cAMP, this protein plays a key role in many important physiological processes. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jul 2011]
PHENOTYPE: Targeted disruption of this gene results in a 4-fold increase in basal release of testosterone in isolated Leydig cells as well as a significant increase in the sensitivity to luteinizing hormone, measured as testosterone released into the media. [provided by MGI curators]
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Pde8a||
(F):5'- GCAACAATGAGAATGCTCTTTCAG -3'
(R):5'- GAGATGGGCTTACAGACATTAAGC -3'
(F):5'- CTCGTCTGGAGAAAGGATGG -3'
(R):5'- TGGGCTTACAGACATTAAGCTATAG -3'